Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Stockholm - Delayed Quote SEK

Micropos Medical AB (publ) (MPOS.ST)

2.0200
-0.1300
(-6.05%)
At close: April 28 at 4:27:23 PM GMT+2
Loading Chart for MPOS.ST
  • Previous Close 2.1500
  • Open 2.1000
  • Bid 1.9900 x --
  • Ask 2.0200 x --
  • Day's Range 2.0000 - 2.1000
  • 52 Week Range 1.2550 - 3.5100
  • Volume 29,981
  • Avg. Volume 83,861
  • Market Cap (intraday) 266.486M
  • Beta (5Y Monthly) 0.52
  • PE Ratio (TTM) --
  • EPS (TTM) -0.1260
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Micropos Medical AB (publ), a medical device company, develops technologies that enhance the precision in radiotherapy of cancer. Its products include Raypilot receiver, a plate with antennas that receive signals from the Raypilot Hypocath's integrated transmitter; Raypilot software, which interprets the data and presents the localization in 3D and in real-time with sub-millimetre accuracy; Raypilot Hypocath, a a temporary urinary catheter with an integrated transmitter; and Raypilot viewcath it resembles a Raypilot Hypocath without electronics and the transmission function. Micropos Medical AB (publ) was incorporated in 2003 and is based in Gothenburg, Sweden.

www.micropos.se

8

Full Time Employees

December 31

Fiscal Year Ends

--

Sector

--

Industry

Recent News: MPOS.ST

View More

Performance Overview: MPOS.ST

Trailing total returns as of 4/29/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .

YTD Return

MPOS.ST
0.00%
MSCI WORLD (^990100-USD-STRD)
2.10%

1-Year Return

MPOS.ST
0.00%
MSCI WORLD (^990100-USD-STRD)
8.46%

3-Year Return

MPOS.ST
32.21%
MSCI WORLD (^990100-USD-STRD)
29.85%

5-Year Return

MPOS.ST
0.00%
MSCI WORLD (^990100-USD-STRD)
75.30%

Compare To: MPOS.ST

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: MPOS.ST

View More

Valuation Measures

Annual
As of
  • Market Cap

    --

  • Enterprise Value

    --

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -78.71%

  • Return on Equity (ttm)

    -234.55%

  • Revenue (ttm)

    3.82M

  • Net Income Avi to Common (ttm)

    -21.87M

  • Diluted EPS (ttm)

    -0.1260

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    7.97M

  • Total Debt/Equity (mrq)

    2.52%

  • Levered Free Cash Flow (ttm)

    -11.29M

Research Analysis: MPOS.ST

View More

Company Insights: MPOS.ST

Research Reports: MPOS.ST

View More

People Also Watch